Sigma Planning Corp’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,985
| Closed | -$209K | – | 1317 |
|
|
2025
Q1 | $209K | Sell |
16,985
-800
| -4% | -$9.83K | 0.01% | 1112 |
|
|
2024
Q4 | $235K | Sell |
17,785
-950
| -5% | -$12.6K | 0.01% | 1024 |
|
|
2024
Q3 | $361K | Sell |
18,735
-200
| -1% | -$3.85K | 0.01% | 880 |
|
|
2024
Q2 | $389K | Sell |
18,935
-900
| -5% | -$18.5K | 0.01% | 823 |
|
|
2024
Q1 | $472K | Buy |
+19,835
| New | +$472K | 0.01% | 788 |
|
|
2023
Q4 | – | Sell |
-20,750
| Closed | -$301K | – | 1121 |
|
|
2023
Q3 | $301K | Sell |
20,750
-10
| -0% | -$145 | 0.01% | 920 |
|
|
2023
Q2 | $435K | Sell |
20,760
-2,490
| -11% | -$52.1K | 0.02% | 788 |
|
|
2023
Q1 | $491K | Sell |
23,250
-2,690
| -10% | -$56.8K | 0.02% | 798 |
|
|
2022
Q4 | $660K | Buy |
25,940
+300
| +1% | +$7.64K | 0.02% | 652 |
|
|
2022
Q3 | $616K | Buy |
25,640
+1,800
| +8% | +$43.2K | 0.02% | 647 |
|
|
2022
Q2 | $459K | Sell |
23,840
-750
| -3% | -$14.4K | 0.02% | 789 |
|
|
2022
Q1 | $427K | Hold |
24,590
| – | – | 0.01% | 897 |
|
|
2021
Q4 | $538K | Sell |
24,590
-200
| -0.8% | -$4.38K | 0.02% | 812 |
|
|
2021
Q3 | $474K | Sell |
24,790
-450
| -2% | -$8.6K | 0.01% | 839 |
|
|
2021
Q2 | $433K | Sell |
25,240
-200
| -0.8% | -$3.43K | 0.01% | 879 |
|
|
2021
Q1 | $569K | Sell |
25,440
-85
| -0.3% | -$1.9K | 0.02% | 709 |
|
|
2020
Q4 | $568K | Sell |
25,525
-600
| -2% | -$13.4K | 0.02% | 639 |
|
|
2020
Q3 | $386K | Buy |
26,125
+100
| +0.4% | +$1.48K | 0.02% | 693 |
|
|
2020
Q2 | $386K | Buy |
+26,025
| New | +$386K | 0.02% | 685 |
|
|
2019
Q3 | – | Sell |
-12,280
| Closed | -$114K | – | 1042 |
|
|
2019
Q2 | $114K | Buy |
+12,280
| New | +$114K | 0.01% | 936 |
|